Vijaya Iragavarapu

Trained in tumor immunology. She studied the role of proinflammatory molecules, e.g. CHI3L1 and Semaphorin 7A promote breast tumor progression. Her research involves delineating mechanisms of metastasis with the focus of inhibiting end-stage breast cancer using novel agents.